Accessibility Menu
Carl Zeiss Meditec Ag logo

Carl Zeiss Meditec Ag(OTC) CZMWY

Current Price$31.40
Market Cap$2.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+265%
5 Year-84%
1 Year-47%
1 Month+0%
Carl Zeiss Meditec Ag last closing stock price
MetricPriceDate
Last closeUSD 31.402026-07-24
Carl Zeiss Meditec Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.02%USD 33.412026-07-17
1 month+0.02%USD 31.402026-06-24
3 month+1.64%USD 30.892026-04-24
Year to date-31.43%USD 45.792025-12-31
1 year-46.8%USD 59.022025-07-24
3 year-71.27%USD 109.292023-07-25
5 year-84.04%USD 196.722021-07-23
Since inception+264.78%USD 8.612008-12-12

Carl Zeiss Meditec Ag Financials at a Glance

Market Cap

$2.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.65B

Net Income (TTM)

€90.16M

EPS (TTM)

$1.25

P/E Ratio

24.86

Dividend

$0.63

Beta (Volatility)

1.05 (Average)

Price

$31.40

Volume

650

Open

$31.33

Previous Close

$31.40

Daily Range

$31.26 - $31.62

52-Week Range

$26.65 - $60.11

Estimated Earnings Date

Dec 10, 2026

CZMWY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Carl Zeiss Meditec Ag

Carl Zeiss Meditec AG is a leading global medical technology company based in Jena, Germany. The firm specializes in ophthalmic devices and microsurgery, providing innovative solutions for healthcare professionals worldwide.

Products and Services
  • Ophthalmic devices for cataract, retinal, and refractive surgeries
  • Advanced visualization tools for microsurgery across various medical fields
  • Comprehensive solutions for healthcare institutions and professionals
Growth Outlook
  • Revenue of €1.00 billion reported in the latest quarter, indicating strong demand
  • Consistent investment in R&D, with €167 million allocated in the recent quarter
  • Positive market trends in healthcare technology support future expansion
Financial Highlights
  • Net income of €14.87 million in the latest quarter, reflecting operational efficiency
  • TTM revenue of €3.06 billion, showcasing robust financial performance
  • Dividend yield of 2.07%, indicating a commitment to returning value to shareholders
Carl Zeiss Meditec AG operates in a dynamic sector, focusing on advanced medical technologies that cater to the growing needs of healthcare providers. The company's commitment to innovation is evident in its substantial investment in research and development, which positions it well for future growth. Recent financial performance highlights a strong revenue base and profitability, making it an attractive option for investors interested in the healthcare technology sector. The company's diverse product offerings and global reach further enhance its potential for sustained growth in the coming years.
AI Generated • Jul 1, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

5,784

CEO

Maximilian Foerst

Website

www.zeiss.de

Headquarters

Jena, TH 07745, DE

CZMWY Financials

Key Financial Metrics (TTM)

Gross Margin

50.81%

Operating Margin

6.15%

Net Income Margin

3.41%

Return on Equity

4.27%

Return on Capital

8.53%

Return on Assets

2.69%

Earnings Yield

4.02%

Dividend Yield

2.03%

Payout Ratio

53.52%

Stock Overview

Market Cap

$2.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

87.54M

Volume

650

Avg. Volume

3.65K

Financials (TTM)

Gross Profit

€1.63B

Operating Income

€161.36M

EBITDA

€391.88M

Operating Cash Flow

€356.09M

Capital Expenditure

-€29.19M

Free Cash Flow

€367.38M

Cash & ST Invst.

€23.92M

Total Debt

€618.20M

Carl Zeiss Meditec Ag Performance Analysis

Carl Zeiss Meditec Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30EUR 2,057,763,2554.6%
20232023-09-30EUR 2,226,938,0108.2%
20242024-09-30EUR 2,239,604,4120.6%
20252025-09-30EUR 2,459,407,1699.8%
Carl Zeiss Meditec Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-1.9%
Q42025-09-3014.2%
Q12025-12-31-25.6%
Q22026-03-31115.1%
Carl Zeiss Meditec Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30EUR 3.5512.6%
20232023-09-30EUR 3.46-2.6%
20242024-09-30EUR 2.18-37.0%
20252025-09-30EUR 1.78-18.3%
Carl Zeiss Meditec Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-36.5%
Q42025-09-30172.7%
Q12025-12-31-106.7%
Q22026-03-31383.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€1.00B

+79.4%

Gross Profit

€497.29M

+64.8%

Gross Margin

49.50%

N/A

Market Cap

$2.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$469.08K

N/A

Employees

5,798

N/A

Net Income

€14.87M

-67.2%

EBITDA

€115.02M

+14.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€23.92M

-53.5%

Total Debt

€618.20M

+320.9%

Accounts Receivable

€624.35M

+5.4%

Inventory

€539.11M

-2.2%

Long Term Debt

€558.32M

+357.0%

Short Term Debt

€59.88M

+142.4%

Return on Assets

2.69%

N/A

Return on Invested Capital

5.73%

N/A

Free Cash Flow

€90.09M

+1655.9%

Operating Cash Flow

€100.28M

+188.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANSLFAnsell Limited
$21.64+0.00%
SNPHFSanten Pharmaceutical Co., Ltd.
$13.05+0.00%
FLMNFFielmann AG
$50.75+0.00%
BUHPFBumrungrad Hospital Public Company Limited
$5.45+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
FFord Motor Company
$14.37+0.02%

Questions About CZMWY

What is the current price of Carl Zeiss Meditec Ag?

Carl Zeiss Meditec Ag is trading at $31.40 per share.

What is the 52-week range for Carl Zeiss Meditec Ag?

Over the past 52 weeks, Carl Zeiss Meditec Ag has traded between $26.65 and $60.11.

How much debt does Carl Zeiss Meditec Ag have?

As of the most recent reporting period, Carl Zeiss Meditec Ag reported total debt of €713.66M.

How much cash does Carl Zeiss Meditec Ag have on hand?

Carl Zeiss Meditec Ag reported €32.04M in cash and cash equivalents in its most recent financial results.

What is Carl Zeiss Meditec Ag’s dividend yield?

Carl Zeiss Meditec Ag currently has a dividend yield of 2.03%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services